Adage Capital Partners
IMVT icon

Adage Capital Partners’s Immunovant IMVT Stock Holding History

Adage Capital Partners’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-413,000
Closed -$10.3M – 1042
2026
Q1 		$10.3M Sell
413,000
-450,000
-52% -$11.7M 0.02% 678
2025
Q4 		$21.9M Buy
863,000
+519,400
+151% +$11.6M 0.03% 456
2025
Q3 		$5.54M Sell
343,600
-120,000
-26% -$1.94M 0.01% 723
2025
Q2 		$7.42M Buy
463,600
+442,400
+2,087% +$6.69M 0.01% 665
2025
Q1 		$362K Sell
21,200
-278,800
-93% -$5.83M ﹤0.01% 817
2024
Q4 		$7.43M Hold
300,000
– – 0.01% 664
2024
Q3 		$8.55M Sell
300,000
-120,000
-29% -$3.54M 0.02% 640
2024
Q2 		$11.1M Buy
420,000
+320,000
+320% +$9.1M 0.02% 579
2024
Q1 		$3.23M Sell
100,000
-1,231,780
-92% -$44.9M 0.01% 741
2023
Q4 		$56.1M Buy
1,331,780
+897,280
+207% +$33M 0.12% 187
2023
Q3 		$16.7M Buy
+434,500
New +$9.82M 0.04% 441
2021
Q1 		– Sell
-1,400,851
Closed -$64.7M – 985
2020
Q4 		$64.7M Buy
1,400,851
+95,851
+7% +$4.43M 0.14% 162
2020
Q3 		$45.9M Sell
1,305,000
-1,061,062
-45% -$31.9M 0.12% 191
2020
Q2 		$57.6M Buy
2,366,062
+1,346,062
+132% +$28.8M 0.15% 160
2020
Q1 		$15.9M Hold
1,020,000
– – 0.05% 375
2019
Q4 		$16.2M Buy
+1,020,000
New +$11.4M 0.04% 423

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Adage Capital Partners's IMVT Position: Q2 2026 in Review

Adage Capital Partners sold out of Immunovant (IMVT) in Q2 2026, closing a stake of 413,000 shares — an estimated $10.3M sold.

Adage Capital Partners first reported a position in IMVT in Q4 2019 and held it in 16 quarters. The position peaked at $64.7M in Q4 2020. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Adage Capital Partners reported no remaining Immunovant position as of Q2 2026 after selling out during the quarter.
  • Adage Capital Partners sold 413,000 Immunovant shares in Q2 2026, an estimated $10.3M.
  • Adage Capital Partners first reported a position in Immunovant in Q4 2019 and held it in 16 quarters.
  • Adage Capital Partners's Immunovant position peaked at $64.7M in Q4 2020.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.